39 related articles for article (PubMed ID: 15800941)
1. Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).
Tohkin M; Kakudo S; Kasai H; Arita H
Cancer Immunol Immunother; 1994 Sep; 39(3):155-60. PubMed ID: 7522963
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health.
Galiana-Melendez F; Huot JR
Curr Osteoporos Rep; 2024 Apr; ():. PubMed ID: 38649653
[TBL] [Abstract][Full Text] [Related]
3. Role of myokines and osteokines in cancer cachexia.
Pin F; Bonewald LF; Bonetto A
Exp Biol Med (Maywood); 2021 Oct; 246(19):2118-2127. PubMed ID: 33899538
[TBL] [Abstract][Full Text] [Related]
4. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
5. Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.
Yoshimura M; Uezono Y; Ueta Y
J Physiol Sci; 2015 Sep; 65(5):385-95. PubMed ID: 26123258
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein stimulates plasma renin activity via its anorexic effects on sodium chloride intake.
Atchison DK; Westrick E; Szandzik DL; Gordish KL; Beierwaltes WH
Am J Physiol Endocrinol Metab; 2012 Aug; 303(4):E457-63. PubMed ID: 22649069
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector.
Enomoto T; Furuya Y; Tomimori Y; Mori K; Miyazaki J; Yasuda H
J Bone Miner Metab; 2011 Jul; 29(4):414-21. PubMed ID: 21063739
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for antibody discrimination between two hormones that recognize the parathyroid hormone receptor.
McKinstry WJ; Polekhina G; Diefenbach-Jagger H; Ho PW; Sato K; Onuma E; Gillespie MT; Martin TJ; Parker MW
J Biol Chem; 2009 Jun; 284(23):15557-63. PubMed ID: 19346515
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.
Lorch G; Gilmore JL; Koltz PF; Gonterman RM; Laughner R; Lewis DA; Konger RL; Nadella KS; Toribio RE; Rosol TJ; Foley J
Br J Cancer; 2007 Jul; 97(2):183-93. PubMed ID: 17533397
[TBL] [Abstract][Full Text] [Related]
10. The stem cell niche in health and leukemic disease.
Scadden DT
Best Pract Res Clin Haematol; 2007 Mar; 20(1):19-27. PubMed ID: 17336251
[TBL] [Abstract][Full Text] [Related]
11. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
12. [PTHrP and cancer cachexia].
Onuma E; Okabe H
Clin Calcium; 2008 Apr; 18(4):489-98. PubMed ID: 18379031
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.
Onuma E; Tsunenari T; Saito H; Sato K; Yamada-Okabe H; Ogata E
Int J Cancer; 2005 Sep; 116(3):471-8. PubMed ID: 15800941
[TBL] [Abstract][Full Text] [Related]
15. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
16. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
